Eli Lilly (LLY) EBIT (2009 - 2026)
Eli Lilly's EBIT was $12.79 billion in Q3 2026, up 59.4% from $8.02 billion a year earlier and up 8.8% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) EBIT (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Eli Lilly's EBIT was $42.95 billion through Sep 30, 2026, up 67.5% year-over-year; for FY2025, it came in at $29.21 billion, up 80.6% from FY2024.
- EBIT has now increased for six consecutive years, with a five-year compound annual growth rate of 33.7% (FY2020 to FY2025).
- In earlier years, EBIT was $16.18 billion in FY2024 (+57.7%), $10.26 billion in FY2023 (+27.6%), $8.04 billion in FY2022 (+9.7%) and $7.33 billion in FY2021 (+7.3%).
- The Q3 2026 figure marks the highest quarterly EBIT in data going back to Q1 2009.
- Compared with a year earlier, EBIT has increased for 14 straight quarters, with growth averaging 77.3% over the last eight quarters.
- The best year-over-year quarter for EBIT over five years was Q1 2025 (growth of 101.1%); the worst was Q1 2023 (a decline of 37.8%).
- Per Business Quant data, LLY's EBIT in the three quarters before Q3 2026 was $11.75 billion (Q2 2026), $9.5 billion (Q1 2026) and $8.9 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 5.59 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 712.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 12.79 Bn |
| Jun 30, 2026 | 11.75 Bn |
| Mar 31, 2026 | 9.50 Bn |
| Dec 31, 2025 | 8.90 Bn |
| Sep 30, 2025 | 8.02 Bn |
| Jun 30, 2025 | 7.02 Bn |
| Mar 31, 2025 | 5.27 Bn |
| Dec 31, 2024 | 5.34 Bn |
| Sep 30, 2024 | 4.35 Bn |
| Jun 30, 2024 | 3.87 Bn |
| Mar 31, 2024 | 2.62 Bn |
| Dec 31, 2023 | 3.01 Bn |
| Sep 30, 2023 | 3.43 Bn |
| Jun 30, 2023 | 2.22 Bn |
| Mar 31, 2023 | 1.60 Bn |
| Dec 31, 2022 | 2.08 Bn |
| Sep 30, 2022 | 1.74 Bn |
| Jun 30, 2022 | 1.65 Bn |
| Mar 31, 2022 | 2.57 Bn |
| Dec 31, 2021 | 2.35 Bn |
API Access
Eli Lilly EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();